Purchase Order HT001421P0011
- Not listed
- The U.S. Defense Health Agency awarded a firm-fixed-price purchase order contract valued at $134,748.42 to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices and blood and cell technology services. The contract, which is not set aside, has an ultimate completion date of September 30, 2027. Terumo BCT Inc., doing business as CaridianBCT, will provide the agency with FY25 TRIMA SN: 1T05022-81000 medical equipment and services. This contract award is associated with a...
- The Defense Health Agency awarded a $203,822.11 firm fixed-price purchase order to Terumo BCT Inc. (doing business as Caridianbct Inc.) on January 24, 2024, for medical equipment services maintenance. The contract, which carries no small business set-aside designation, is scheduled for completion by January 21, 2028, and will be performed in Bethesda, Maryland. Terumo BCT Inc., a Colorado-based manufacturer of advanced blood and cell technology solutions, specializes in providing maintenance and...
- This federal contract award to Terumo BCT Inc., operating as Terumo Bct, Inc. Division and doing business as Caridianbct, is for preventative maintenance on a TRIMA ACELL blood collection system. The contract, valued at $60,618.00, was awarded by the Defense Health Agency, an agency within the U.S. Department of Defense. The contract is a firm fixed-price purchase order and does not have a set-aside designation. Terumo BCT is a foreign-owned, for-profit manufacturer of medical devices and...
- This is a $70,741.88 firm fixed-price purchase order awarded to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices, for the maintenance of Spectra Optia apheresis systems used in the stem cell transplant program of the Defense Health Agency (DHA). The purchase order has an ultimate completion date of November 29, 2027. Terumo BCT Inc. provides a wide range of products and services to federal agencies, including blood bag systems, tubing sets, cell washing equipment, and...
- The Defense Health Agency (DHA) awarded Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices, a $71,808 firm-fixed-price purchase order for BMAC2 60-01 BMAC 60ML PROCED. PACK 1/CAS. This order is not associated with a set-aside contract. Terumo BCT, operating as Caridianbct, is a provider of blood and cell technology services who has supplied various products and services to federal agencies, including blood bag systems, tubing sets, cell washing equipment, and...
- This is a firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices and provider of blood and cell technology services. The contract, valued at $131,970.76, is for the TRIMA Collection System, Version 5, which is used for blood processing and cellular therapies. Terumo BCT has a history of providing specialized medical equipment and services to various government agencies, including the...
- This federal contract award to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices and blood and cell technology services, is for the supply of TERUMO BCT QUAD CPD-OPTISOL 500ML, a type of medical equipment. The contract, awarded by the Defense Health Agency, has a ceiling value of $30,225.00 and is a firm fixed-price purchase order with an ultimate completion date of August 25, 2021. The contract is not set aside for small businesses. Terumo BCT Inc. has a robust...
- The Defense Health Agency awarded a firm fixed price purchase order to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices and blood and cell technologies, to provide service maintenance for two Spectra Optia Apheresis Machines for a base period of one year and three option years. The total ceiling value of the contract is $53,042. This sole-source award was made under the authority of FAR 13.106-1(b)(1)(i), as Terumo BCT is the original equipment manufacturer and the...
- This is a federal contract award to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices and blood and cell technology services. The contract, valued at $638,666.00, is a firm fixed-price Blanket Purchase Agreement (BPA) call order with the Defense Health Agency (DHA) for the supply of TRIMA ACCEL RBC/PLATELET/PLASMA systems and associated services. The contract is not set aside for small businesses. The award indicates that Terumo BCT has a significant federal contract...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Terumo BCT Inc. for TRIMA ACCEL medical supplies. The contract has a ceiling value of $77,551.80 and was awarded on November 28, 2018, with a completion date of September 23, 2019. Terumo BCT Inc. is a foreign-owned, for-profit manufacturer of medical devices and provider of blood and cell technology services. The company has established itself as a key supplier to various...
The Defense Health Agency awarded a firm-fixed-price purchase order contract to Terumo BCT Inc., a foreign-owned, for-profit medical device manufacturer, for the maintenance of TERUMOBCT medical equipment. The contract, valued at $190,103.00, has a period of performance through November 12, 2023. This contract is not set aside for small businesses. Terumo BCT, headquartered in Lakewood, Colorado, is a global leader in developing advanced medical technologies focused on blood processing, collection, and cellular therapies. The company provides a comprehensive range of specialized medical equipment, consumables, and maintenance services to various U.S. government healthcare agencies, with a primary emphasis on blood management technologies, apheresis systems, and related medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $63.7k | 11/7/22 | |
| P00003 | Other Administrative Action | $0 | 6/28/22 | |
| P00002 | Exercise an Option | $63.7k | 11/24/21 | |
| P00001 | Other Administrative Action | $0 | 11/13/20 | |
| Not listed | Not listed | $62.7k | 11/12/20 |